DNA
Price
$8.33
Change
+$0.21 (+2.59%)
Updated
Oct 4 closing price
37 days until earnings call
VRCA
Price
$1.31
Change
-$0.14 (-9.66%)
Updated
Oct 4 closing price
33 days until earnings call
Ad is loading...

DNA vs VRCA

Header iconDNA vs VRCA Comparison
Open Charts DNA vs VRCABanner chart's image
Ginkgo Bioworks Holdings
Price$8.33
Change+$0.21 (+2.59%)
Volume$1.13M
CapitalizationN/A
Verrica Pharmaceuticals
Price$1.31
Change-$0.14 (-9.66%)
Volume$1.73M
CapitalizationN/A
View a ticker or compare two or three
DNA vs VRCA Comparison Chart
Loading...
DNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DNA vs. VRCA commentary
Oct 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNA is a StrongBuy and VRCA is a StrongSell.

COMPARISON
Comparison
Oct 05, 2024
Stock price -- (DNA: $8.33 vs. VRCA: $1.31)
Brand notoriety: DNA and VRCA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNA: 69% vs. VRCA: 146%
Market capitalization -- DNA: $452.94M vs. VRCA: $61.87M
DNA [@Biotechnology] is valued at $452.94M. VRCA’s [@Biotechnology] market capitalization is $61.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNA’s FA Score shows that 1 FA rating(s) are green whileVRCA’s FA Score has 0 green FA rating(s).

  • DNA’s FA Score: 1 green, 4 red.
  • VRCA’s FA Score: 0 green, 5 red.
According to our system of comparison, DNA is a better buy in the long-term than VRCA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNA’s TA Score shows that 4 TA indicator(s) are bullish while VRCA’s TA Score has 4 bullish TA indicator(s).

  • DNA’s TA Score: 4 bullish, 4 bearish.
  • VRCA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VRCA is a better buy in the short-term than DNA.

Price Growth

DNA (@Biotechnology) experienced а +2.97% price change this week, while VRCA (@Biotechnology) price change was -22.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was -5.77%.

Reported Earning Dates

DNA is expected to report earnings on Nov 11, 2024.

VRCA is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNA($453M) has a higher market cap than VRCA($61.9M). VRCA YTD gains are higher at: -82.104 vs. DNA (-87.678). VRCA has higher annual earnings (EBITDA): -77.18M vs. DNA (-763.83M). DNA has more cash in the bank: 730M vs. VRCA (31.9M). VRCA has less debt than DNA: VRCA (46.3M) vs DNA (452M). DNA has higher revenues than VRCA: DNA (184M) vs VRCA (13.9M).
DNAVRCADNA / VRCA
Capitalization453M61.9M732%
EBITDA-763.83M-77.18M990%
Gain YTD-87.678-82.104107%
P/E RatioN/AN/A-
Revenue184M13.9M1,324%
Total Cash730M31.9M2,288%
Total Debt452M46.3M976%
FUNDAMENTALS RATINGS
VRCA: Fundamental Ratings
VRCA
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNAVRCA
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 9 days ago
87%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
DNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCHX1.830.02
+1.10%
Marchex
TRNO65.750.63
+0.97%
Terreno Realty Corp
CUBI45.340.30
+0.67%
Customers Bancorp
MELI1960.000.80
+0.04%
MercadoLibre
ESQ61.25-0.08
-0.13%
Esquire Financial Holdings

VRCA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRCA has been loosely correlated with TCBP. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VRCA jumps, then TCBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRCA
1D Price
Change %
VRCA100%
-9.66%
TCBP - VRCA
41%
Loosely correlated
+14.83%
SCPX - VRCA
38%
Loosely correlated
+0.55%
DNA - VRCA
33%
Loosely correlated
+2.59%
TNYA - VRCA
30%
Poorly correlated
-6.84%
SLNO - VRCA
29%
Poorly correlated
+1.39%
More